JUNS
JUNS
NASDAQ · Pharmaceuticals

Jupiter Neurosciences Inc

Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks
$5.10
-0.53 (-9.45%)
As of Aug 8, 10:53 PM ET ·
JUNS News2 articles
Jupiter Neurosciences Stock Retreats After Securing U.S. MDMA Rights
Jupiter Neurosciences shares fell from a 67% rally after securing U.S. rights for a trial-stage MDMA drug, with the stock rising only 6.2% amid concerns over financing and dilution.
Markets
Jupiter Neurosciences Shares Plunge on $100M MDMA Deal and Dilutive Offering
Jupiter Neurosciences shares fell 37% to $0.205 after announcing a $100M licensing deal for MDMA drug ALA-002 and a $2M stock offering, with trading volume exceeding 230 million shares.
Markets